Eran Kosover

Company: MyBiotics

Job title: Chief Business Officer

Seminars:

Listen to how Partnerships & Collaborations Have Helped My-Biotics Successfully Create an Expansive Product Pipeline 4:00 pm

MyBiotics’ SuperDonor technology – a unique disruptive technology for scalable and standardized artificial FMT MBX-SD-202 – successful completion of Phase I safety with artificial FMT based on the SuperDonor technology MBX-SD-202 – planned clinical development for recurrent C. diff infectionRead more

day: Day Two – Track C – 2